|
 |
| |
| |
Pipeline to Partnerships (P2P)
| Category/Phase: Allergy/Immunology / Research |
|
|
|
|
  represents column sort |
|
|
Title
|
Company Name
|
Platform / Modality
|
Target
|
Investor/Partner Relations
|
| A New Class of Pan-HER Antagonists to Treat Cancer |
Molecular LogiX |
Biologic |
HER family of receptor tyrosine kinases |
VC, Strategic Partner |
| A Novel Holographic Detector for Remote Sensing of Environmental Hazards |
AlphaSniffer, LLC |
Point of Care |
infectious disease agents, including biological warfare agents, for clinical application and also infrastructure and personnel protection |
VC, Licensing, Strategic Partner, Other |
| Novel Technology for cost-effective production of improved antibodies |
ApoLife, Inc. |
Antibody |
CLL and breast cancer |
VC, Licensing, Manufacturing, Strategic Partner |
|
|
|
|
|
|